2020-12-02
Camurus AB today announced that Camurus licensee Braeburn has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding its new drug application (NDA) for Brixadi.
Read the full press release: https://www.camurus.com/
2022-10-03
In alignment with the group’s investment philosophy, Sandberg Development has invested in the Swedish water innovati…
Read more2022-08-16
Sandberg Development will be the main sponsor of the reception of new students in the Embedded Electronics Engineeri…
Read more2022-04-29
On Thursday, April 28, it was finally time for RESCUE Intellitech to launch their new machine, the DeconWasher™ Pro…
Read more2022-04-06
Camurus Annual Report for 2021 is now available at the company's website.
Read more2022-04-05
On March 21, 2022, Stefan Persson joined the Sandberg Development Group as the new President and CEO. He takes over…
Read more